Hypothesis: is accumulation of a furan dicarboxylic acid (3-carboxy-4- methyl-5-propyl-2-furanpropanoic acid) related to the neurological abnormalities in patients with renal failure?
The Plasma concentrations of a lipophilic furan dicarboxylic acid (3- carboxy-4-methyl-5-propyl-2-fluranpropanoic acid; 5-propyl FPA), which is highly bound to albumin and not removed by haemodialysis, have been measured in patients with renal impairment who were not dialysis dependent or who were t...
Auteurs principaux: | Costigan, MG, Callaghan, C, Lindup, W |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
1996
|
Documents similaires
-
Relationship of plasma 3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid concentration with OATP1B activity in patients with chronic kidney disease
par: Hiroyuki Ono, et autres
Publié: (2024-02-01) -
Circulating 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with hyperglycemia and β cell dysfunction in a Chinese population
par: Shan Zhang, et autres
Publié: (2017-06-01) -
3-Carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) induces cell death through ferroptosis and acts as a trigger of apoptosis in kidney cells
par: Jung Sun Park, et autres
Publié: (2023-02-01) -
Direct synthesis of furan-2,5-dicarboxylic acid monoamides
par: Róbert Fischer, et autres
Publié: (2015-09-01) -
Process Analysis of Furan Dicarboxylic Acid Production from Lignocellulose Biomass
par: Dang Saebea, et autres
Publié: (2024-07-01)